Fundraising Fox

Decade

3 known investors

Decade develops targeted cancer therapies using AI and high-throughput data analysis to match treatments to individual patients' tumor molecular profiles.

AI & Machine LearningBiotechDigital Health

Investors · 3

Tau VenturesPalo Alto · $500K
BenchmarkreportedSan Francisco · $100K – $30M
GreenoaksreportedSan Francisco · $1M – $50M

Funding

SEC filings, press & company announcements

$85M disclosed across 1 of 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Alice Raises $140M: Decade of Adversarial Data Powers Enterprise AI Security Pushtechtimes.com · Aug 2026Decade Raises Record $85 Million Seed Round To Build AI Wealth Advisory Platformpulse2.com · Aug 2026Decade raises $85M seed round to launch AI-powered wealth advisory platform - LatamListlatamlist.com · Aug 2026Decade Raises $85M in Seed Fundingfinsmes.com · Aug 2026Ex-Nubank team raises $85m for AI adviser Decadethenextweb.com · Aug 2026Decade Raises $85M in Latin America's Largest Seed Round to Create a New Generation of Millionaires with AIbusinesswire.com · Aug 2026

Frequently asked questions

What does Decade do?
Decade develops targeted cancer therapies using AI and high-throughput data analysis to match treatments to individual patients' tumor molecular profiles.
Who are Decade's investors?
Decade's investors include Tau Ventures, Benchmark, Greenoaks.
How much funding has Decade raised?
Decade has disclosed $85M raised across 1 of its 2 known rounds.